Topic: Health
Scientists at Nanyang Technological University created new nanoparticles called SOLIDs to remove excess immune mediators from the bloodstream. These particles can capture target molecules and direct them towards lysosomes, where they are broken down. This technology has the potential to treat life-threatening medical conditions such as sepsis and acute lung injury.
The human body's defense system, called the immune system, is designed to fight off infections and injuries. However, sometimes it can become too active and produce too many immune mediators, which are fragments of genetic material or proteins that regulate immune responses. Excess immune mediators in the bloodstream can cause severe inflammation, leading to life-threatening medical conditions such as sepsis and acute lung injury.
Sepsis is an extreme response to a bacterial, viral, or fungal infection, while acute lung injury occurs when inflammation causes fluid to leak into the lungs, impairing breathing. To address this issue, some scientists have been trying to find ways to remove excess immune mediators from the bloodstream.
Researchers at Nanyang Technological University recently engineered new nanoparticles called SOLIDs (stiffness-oriented lysosome self-sorting nanodegraders). These particles are designed to capture target molecules in the bloodstream and direct them towards lysosomes, where they can be broken down. The team's lead researcher, Dr. Jiayan Wu, explained that lysosomes are natural locations for protein degradation in cells.
The new nanoparticles have two main layers: a rigid inner core made of semiconducting polymers (SPs) and an outer coating based on PEG, a biocompatible polymer widely used in biomedical applications. The SP-based inner core helps the particles travel inside cells and reach lysosomes, while the PEG shell captures molecules in the bloodstream. This unique design allows SOLIDs to exert greater mechanical stress on cell membranes, facilitating their uptake by cells.
The researchers' goal is to use these nanoparticles to treat immune-related diseases driven by excess immune mediators. Their study was published in Nature Nanotechnology and has the potential to improve treatment options for patients with life-threatening medical conditions.
Why It Matters
This technology could lead to better treatments for sepsis and acute lung injury, which are major causes of death worldwide. India is also struggling with high rates of these diseases, so this breakthrough could have a significant impact on public health in the country.
Key Facts
- Scientists at Nanyang Technological University created new nanoparticles called SOLIDs to remove excess immune mediators from the bloodstream.
- These particles can capture target molecules and direct them towards lysosomes, where they are broken down.
- The technology has the potential to treat life-threatening medical conditions such as sepsis and acute lung injury.
- Sepsis is an extreme response to a bacterial, viral, or fungal infection, while acute lung injury occurs when inflammation causes fluid to leak into the lungs.
- The study was published in Nature Nanotechnology.
Key Terms
- Lysosomes
- Organelles that break down and recycle cellular waste
- Immune mediators
- Fragments of genetic material or proteins that regulate immune responses
Implications
This technology could lead to better treatments for sepsis and acute lung injury, which are major causes of death worldwide. India is also struggling with high rates of these diseases, so this breakthrough could have a significant impact on public health in the country.
Leave a comment